Ki-67 expression in hydatidiform moles and hydropic abortions

Iranian Red Crescent Medical Journal

Volumn 15, Issue 7, 2013, Pages 590-594

  Khooei, Alireza ^a   Pasdar, Fatemeh Atabaki ^b   Fazel, Alireza ^c   Mahmoudi, Mahmoud ^d   Nikravesh, Mohammad Reza ^c   Delui, Mohammad Khaje ^c   Pourheydar, Bagher ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Abortion; Hydatidiform mole; Immunohistochemistry; Ki 67 antigen

Indexed keywords

KI 67 ANTIGEN;

ABORTION; ARTICLE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; EMBRYO; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; HYDROPIC ABORTION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN EXPRESSION;

EID: 84885722544     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: 10.5812/ircmj.5348     Document Type: Article

References (24)

1. Soper JT, Mutch DG, Schink JC. Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53. Gynecol Oncol. 2004;93(3):575-85.
2. Bracken MB. Incidence and aetiology of hydatidiform mole: an epidemiological review. Br J Obstet Gynaecol. 1987;94(12):1123-35.
3. Rice LW, Berkowitz RS, Lage JM, Goldstein DP, Bernstein MR. Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol. 1990;36(3):358-62.
4. Howat AJ, Beck S, Fox H, Harris SC, Hill AS, Nicholson CM, et al. Can histopathologists reliably diagnose molar pregnancy? J Clin Pathol. 1993;46(7):599-602.
5. Fukunaga M, Katabuchi H, Nagasaka T, Mikami Y, Minamiguchi S, Lage JM. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol. 2005;29(7):942-7.
6. Sebire NJ, Rees H. Diagnosis of gestational trophoblastic disease in early pregnancy. Current Diagnostic Pathology. 2002;8(6):430-440.
7. Fukunaga M, Ushigome S, Sugishita M. Application of flow cytometry in diagnosis of hydatidiform moles. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 1993;6(3):353.
8. Ronnett BM, DeScipio C, Murphy KM. Hydatidiform moles: ancillary techniques to refine diagnosis. Int J Gynecol Pathol. 2011;30(2):101-16.
9. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182(3):311-22.
10. Rosai J. Female reproductive system. Ackerman's surgical pathology. 10 ed. St Louis: Mosby; 2011. p. 1639-45.
11. Hussein MR. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles. Exp Mol Pathol. 2009;87(1):63-9.
12. Erfanian M, Sharifi N, Omidi AA. P63 and Ki-67 expression in trophoblastic disease and spontaneous abortion. J Res Med Sci. 2009;14(6):375-84.
13. Yazaki-Sun S, Daher S, de Souza Ishigai MM, Alves MT, Mantovani TM, Mattar R. Correlation of c-erbB-2 oncogene and p53 tumor suppressor gene with malignant transformation of hydatidiform mole. J Obstet Gynaecol Res. 2006;32(3):265-72.
14. Schammel DP, Bocklage T. p53 PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study. Int J Gynecol Pathol. 1996;15(2):158-66.
15. Atabaki Pasdar F, Khooei A, Fazel A, Mahmoudi M, Nikravesh MR, Khaje Delui M. Diagnostic value of lectins in differentiation of molar placentas. Iran J Basic Med Sci. 2012;15(6):1140-7.
16. Kihara M, Matsui H, Seki K, Nagai Y, Wake N, Sekiya S. Genetic origin and imprinting in hydatidiform moles. Comparison between DNA polymorphism analysis and immunoreactivity of p57KIP2. J Reprod Med. 2005;50(5):307-12.
17. Osterheld MC, Caron L, Chaubert P, Meagher-Villemure K. Combination of immunohistochemistry and ploidy analysis to assist histopathological diagnosis of molar diseases. Clin Med Pathol. 2008;1:61-7.
18. Boyd PatriciaA. Quantitative structure of the normal human placenta from 10 weeks of gestation to term. Early human development. 1984;9(4):297-307.
19. Wolf HK, Michalopoulos GK. Proliferating cell nuclear antigen in human placenta and trophoblastic disease. Pediatr Pathol. 1992;12(2):147-54.
20. Cheville JC, Robinson R, Benda JA. Evaluation of Ki-67 (MIB-1) in placentas with hydropic change and partial and complete hydatidiform mole. Pediatr Pathol Lab Med. 1996;16(1):41-50.
21. Kale A, Soylemez F, Ensari A. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease. Am J Obstet Gynecol. 2001;184(4):567-74.
22. Ostrzega N, Phillipson J, Liu P. Proliferative activity in placentas with hydropic change and hydatidiform mole as detected by Ki-67 and proliferating cell nuclear antigen immunostaining. Am J Clin Pathol. 1998;110(6):776-81.
23. Cheung AN, Ngan HY, Collins RJ, Wong YL. Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen. J Clin Pathol. 1994;47(7):601-4.
24. Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol. 2001;20(1):31-47.